StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | PACB Pacific Biosciences | $1.23 | -3.54% | — | — | — | — | — | 58 |
| 1 | NVO Novo Nordisk | $45.86 | -2.61% | — | — | — | — | — | 66 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $45.74 |
| -0.30% |
| — |
| — |
| — |
| — |
| — |
| 57 |
| 3 | REGN Regeneron | $715.43 | -0.62% | — | — | — | — | — | 48 |
| 4 | LLY Eli Lilly | $1006.93 | -0.89% | — | — | — | — | — | 48 |
| 5 | AMGN Amgen | $335.69 | -0.23% | — | — | — | — | — | 44 |
| 6 | VRTX Vertex Pharma | $450.88 | -0.48% | — | — | — | — | — | 44 |
| 7 | MRNA Moderna | $50.10 | -0.63% | — | — | — | — | — | 44 |
| 8 | GILD Gilead Sciences | $132.34 | -0.53% | — | — | — | — | — | 37 |
| 9 | BNTX BioNTech | $92.00 | -0.25% | — | — | — | — | — | 33 |